Largest U.S. pediatricians’ association; policy leader on child health
Vaccines updated this year are arriving as flu season begins, with updates to RSV and COVID-19 vaccines. Guidance remains in flux as federal rules face court challenges, while medical groups publish independent guidelines to ensure broad, science-based protection.
The US has confirmed two measles deaths in Lancaster County, Pennsylvania, marking the first fatalities this year. The CDC has removed the deaths from its database after a new director ordered a review of the cases, prompting questions about vaccine policy and public health communication amid rising case counts in 2026.
New data from Truveta shows vitamin K refusals at birth have surged in 2026, driven by political messaging around vaccines. The rate of non-administration increased sharply in the first half of the year, with 81-fold higher risk of life-threatening bleeding without the shot for infants in their first six months. Health officials warn the trend risks newborn lives as US debates policy changes echoed by Kennedy and Trump.
The American College of Obstetricians and Gynecologists has released its own maternal immunization schedule, diverging from the CDC’s guidance amid policy changes and vaccine misinformation. The plan endorses influenza, COVID-19, RSV, and Tdap vaccines during pregnancy, with additional vaccines for certain risk groups and postpartum/breastfeeding vaccination details. Health professionals say hesitancy remains a challenge as providers seek to align patient care with evidence-based guidance.
The Kennedy administration has filed motions to expedite federal vaccine-advisory meetings ahead of the fall flu season. Courts have frozen previous immunization policy changes, while new appointees prepare to form a fresh advisory panel.
The Federal Trade Commission and several states have filed a Texas suit against the World Professional Association for Transgender Health (WPATH), accusing the group of deceptive claims about gender-affirming care for minors and of profiting from those claims. WPATH says guidelines are individualized. The action follows ongoing FTC probes and a broader fight over minors’ gender-affirming treatments.
Moderna’s mFlusiva has secured an advisory committee vote in favor of approval for adults 50 and older. The decision follows earlier FDA scrutiny and a high-profile dispute over study design, with the committee citing robust efficacy and a solid safety profile.
Utah faces a widening measles outbreak affecting 22 of 29 counties, with infection clusters in undervaccinated communities. Officials warn that school start and cooler weather could trigger a renewed surge. ProPublica links endemism questions to national measles status.
New safety measures are being rolled out after multiple drownings highlighted by the Independent and AP reports. The push emphasizes swift rescue, pool safety, and funding for swimming lessons following a family tragedy that inspired a charitable foundation.
Andrea Shaw has been indicted on two counts of first-degree murder in the May 2025 deaths of her 18-month-old twins, Dallas and Tyson, in Payette, Idaho. Prosecutors say she suffocated them; defense links the deaths to vaccines. Shaw faces life imprisonment or the death penalty if convicted.
Multiple sources report a rebound in measles cases across the U.S., with 2,260 confirmed cases now documented in 44 states and D.C. Public health officials say vaccination coverage below 95% threatens herd immunity and risks losing measles elimination status. A review in November will decide on that status.
The CDC reports 2,318 measles cases in 2026, making it the worst year in decades. Outbreaks in South Carolina, Utah and Arizona have prompted renewed concern over vaccination coverage as officials weigh loss of measles-free status.
Measles cases in the U.S. have surged to 2,371 this year, the highest in years, prompting renewed calls for vaccination amid political and public health pressures. Outbreaks are intensifying in several states as officials warn that vaccination alone may not curb spread. Health Secretary Kennedy faces scrutiny over his vaccine stance while states push to bolster immunization programs.
Back-to-school season finds backpacks carrying more devices, notebooks and gear, with experts warning about potential strain. The American Academy of Pediatrics says signs of overload include leaning forward or difficulty walking, and advocates lightening loads where possible. Teachers are urging families to audit daily contents, balancing technology and traditional textbooks as districts weigh the role of print vs. digital learning.
Moderna has won FDA approval for its mRNA flu vaccine mFlusiva for adults 50–64 and accelerated approval for those 65 and older. The decision follows a contentious review earlier this year, a unanimous advisory panel recommendation in June and political disputes inside US health agencies over mRNA vaccines. Retail availability is expected in coming weeks.
President Trump has signed an executive order directing federal health officials to cut the federal recommended childhood vaccine list, to split the combined MMR vaccine into separate measles, mumps and rubella doses once single‑disease products are available, and to space routine immunisations across separate medical visits. Public health groups and drugmakers have said the changes lack scientific support and will increase missed vaccinations during a major U.S. measles outbreak.
The White House has issued an executive order reducing federal vaccine recommendations to 11 core shots and urging the separation of the MMR vaccine into three injections. Physicians warn the move risks confusion and slower protection, while public health groups stress that CDC guidance remains unchanged and vaccines should proceed as recommended.
The administration has finalized a rule that ends federal Medicaid and CHIP funding for gender-affirming care for minors, including puberty blockers, hormones, and surgeries. Mental health services remain funded. Seventeen states currently cover some degree of gender-affirming care under Medicaid and CHIP, while many hospitals have paused treatments.